COVID-19
Conditions
Interventions
Folic acid oral tablet.
Already established protocols for prevevntion and treatment
Sponsors
Faculty of Medicine Cairo university
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Health care works at risk while caring for COVID-19 carriers and cases. 2. Asymptomatic carriers with positive PCR. 3. Non-critical symptomatic COVID-!9 cases diagnosed by PCR.
Exclusion criteria
Exclusion criteria: Critical ICU admitted critical symptomatic COVID-!9 cases diagnosed by PCR. COVID-!9 cases diagnosed by PCR
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| a.The conversion of health care workers at risk of COVID-19 from negative to positive as measured by PCR in the control and intervention groups. b.The conversion from positive to negative in asymptomatic carriers and non-critical symptomatic COVID-19 patients in the control and intervention groups. | — |
Secondary
| Measure | Time frame |
|---|---|
| Rate and number of cases converted from PCR positive to PCR negative and the time needed for such conversion in the experimental as compared to the control group among the populations of Asymptomatic carriers and non-critical cases .and percentage lost from the health care providers due to their infection with COVID-19 virus. | — |
Countries
Egypt
Contacts
Public ContactHala Salah
Dean of the faculty of Medicine and Professor of paediatrics.
Outcome results
None listed